Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 2: the synthesis and biological activities of RPR127963 an orally bioavailable inhibitor
- 29 July 2003
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (18), 3097-3100
- https://doi.org/10.1016/s0960-894x(03)00655-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR Exploration and Effective Bioisosteric Replacement of a phenyl substituentBioorganic & Medicinal Chemistry Letters, 2003
- Sti-571 in Chronic Myelogenous LeukaemiaBritish Journal of Haematology, 2002
- Clinical management of gastrointestinal stromal tumors: Before and after STI-571Human Pathology, 2002
- Restenosis Following Angioplasty in the Swine Coronary Artery Is Inhibited By an Orally Active PDGF-Receptor Tyrosine Kinase Inhibitor, RPR101511ACirculation, 1999
- Mechanism of Action and In Vivo Role of Platelet-Derived Growth FactorPhysiological Reviews, 1999
- Small molecule inhibitors of receptor tyrosine kinasesDrugs of the Future, 1999
- 3-ISOQUINUCLIDONEOrganic Syntheses, 1969